BCL2 and cancer: On the other hand, ARBs exert anti-tumor effects by increasing cancer cell autophagy through the induction of autophagy-related cell death and anti-metastatic activity [52], downregulating Bcl-2 and engaging in caspase-3-induced apoptosis pathways in cancer cells [53].